Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
50.53
-0.25 (-0.49%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Amphastar Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
644.52593.24498.99437.77349.85322.36
Upgrade
Other Revenue
68.3751.16----
Upgrade
Revenue
712.89644.4498.99437.77349.85322.36
Upgrade
Revenue Growth (YoY)
31.80%29.14%13.98%25.13%8.53%9.40%
Upgrade
Cost of Revenue
320.38290.57250.13238.03206.51190.43
Upgrade
Gross Profit
392.51353.82248.86199.74143.34131.92
Upgrade
Selling, General & Admin
88.1580.3966.5967.1262.8663.11
Upgrade
Research & Development
71.7873.7474.7760.9367.2368.85
Upgrade
Operating Expenses
159.92154.13141.36128.05130.09131.96
Upgrade
Operating Income
232.59199.69107.571.6913.25-0.04
Upgrade
Interest Expense
-32.38-27.16-1.85-0.89-0.37-0.12
Upgrade
Interest & Investment Income
9.45.461.320.60.641
Upgrade
Earnings From Equity Investments
-1.47-1.98-1.18-0.21--
Upgrade
Other Non Operating Income (Expenses)
-3.8-3.933.6713.546.22-0.51
Upgrade
EBT Excluding Unusual Items
204.33172.08109.4684.7319.740.33
Upgrade
Asset Writedown
-2.7-2.7----
Upgrade
Legal Settlements
--5.41-12.859.9
Upgrade
Other Unusual Items
----1.8-2.3-
Upgrade
Pretax Income
201.63169.38114.8683.934.6460.23
Upgrade
Income Tax Expense
35.1231.8323.4820.633.5413.72
Upgrade
Earnings From Continuing Operations
166.52137.5591.3963.31.146.51
Upgrade
Minority Interest in Earnings
----1.190.312.43
Upgrade
Net Income
166.52137.5591.3962.121.448.94
Upgrade
Net Income to Common
166.52137.5591.3962.121.448.94
Upgrade
Net Income Growth
63.34%50.51%47.12%4327.37%-97.13%-
Upgrade
Shares Outstanding (Basic)
484849484747
Upgrade
Shares Outstanding (Diluted)
535352504950
Upgrade
Shares Change (YoY)
1.15%1.09%5.31%1.34%-1.57%7.57%
Upgrade
EPS (Basic)
3.442.851.881.300.031.04
Upgrade
EPS (Diluted)
3.152.601.741.250.030.98
Upgrade
EPS Growth
62.07%49.43%39.20%4090.97%-96.96%-
Upgrade
Free Cash Flow
178.13145.3465.1570.5423.410.21
Upgrade
Free Cash Flow Per Share
3.362.741.241.420.480.00
Upgrade
Gross Margin
55.06%54.91%49.87%45.63%40.97%40.92%
Upgrade
Operating Margin
32.63%30.99%21.54%16.38%3.79%-0.01%
Upgrade
Profit Margin
23.36%21.34%18.31%14.19%0.40%15.18%
Upgrade
Free Cash Flow Margin
24.99%22.55%13.06%16.11%6.69%0.06%
Upgrade
EBITDA
284.16237.72132.2794.9534.7818.07
Upgrade
EBITDA Margin
39.86%36.89%26.51%21.69%9.94%5.61%
Upgrade
D&A For EBITDA
51.5738.0424.7723.2721.5318.11
Upgrade
EBIT
232.59199.69107.571.6913.25-0.04
Upgrade
EBIT Margin
32.63%30.99%21.54%16.38%3.79%-0.01%
Upgrade
Effective Tax Rate
17.42%18.79%20.44%24.58%76.34%22.79%
Upgrade
Revenue as Reported
712.89644.4498.99437.77--
Upgrade
Advertising Expenses
-10.48.78.15.84.3
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.